Tag Archives: CVS Health

Programs Covering the Cost of Gene Therapies Increase

Cell and gene therapies are revolutionizing the field of medicine by offering life-changing benefits to people with rare diseases and cancers

Market Access Programs for Gene Therapies Increasing

Payers are planning for an increasing number of gene therapies being approved by developing new coverage programs

It’s a New Year, But Omnicare Continues to Disappoint

Continuing weak margins due to staffing struggles, recent generic introductions, and decreasing reimbursements remain the leading drivers of the poor results

Speculation Intensifies on Kroger and Walgreens Plans

Kroger and Walgreens expanding their relationship to compete against larger companies

Digital Therapeutics Market Continues to Experience Growing Pains

Investment in Digital Therapeutics is expanding rapidly with industry stakeholders working to develop their strategies for success

Will Diplomat Pharmacy Survive?

Diplomat found that competing successfully with large specialty pharmacies owned by Cigna/ESI, CVS Health/Caremark and UnitedHealth/OptumRx has been more difficult than projected

CVS Health Initiatives include Chronic Kidney Care

CVS’s objective is to place consumers at the center of its strategy and help them achieve their best health by strengthening health care locally and making it simpler to use and understand